Differences in SMN levels between the different organs, control or SMA, are therefore unlikely to fully explain the organ-specific effects highlighted by the proteomics data, and rather suggest the presence of tissue/organ-specific pathways that are regulated by SMN during development. Here, SMN1 is linked to proximal spinal muscular atrophy.